Elias Sabbagha
Obstetrics & Gynecology · Chicago, ILNPI 1578622809
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 247 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 33.3% of the total. Reporting peaked in 2022 at $1,311 and has fallen 61.4% since, to $506 in 2023.
Across 247 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Therapeuticsmd, Inc.$315
- Amneal Pharmaceuticals LLC$258
- Exeltis, USA Inc.$256
- Takeda Pharmaceuticals U.S.A., Inc.$237
- IBSA Pharma Inc.$235
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,25099%
- Education$511%
- Gifts$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,434 |
| Therapeuticsmd, Inc. | 18 | $315 |
| Amneal Pharmaceuticals LLC | 13 | $258 |
| Exeltis, USA Inc. | 13 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $237 |
| IBSA Pharma Inc. | 13 | $235 |
| Avion Pharmaceuticals | 11 | $215 |
| Bausch Health US, LLC | 16 | $209 |
| Ascend Therapeutics US, LLC | 23 | $186 |
| Mayne Pharma Commercial LLC | 6 | $132 |
| Lupin Inc. | 6 | $117 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $108 |
| Vertical Pharmaceuticals, LLC | 4 | $93 |
| Biohaven Pharmaceuticals, Inc. | 4 | $91 |
| Hologic Sales And Service, LLC | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Coopersurgical, Inc. | 2 | $47 |
| Novo Nordisk | 2 | $46 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Bayer | 2 | $44 |
| Duchesnay USA Incorporated | 2 | $38 |
| Roche Diagnostics Corporation | 1 | $28 |
| Vistapharm, Inc. | 2 | $27 |
| Agile Therapeutics, Inc. | 1 | $20 |
How this compares
$4,308 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,800 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chicago
- Lee ShulmanChicago$559K
- Maria TamChicago$378K
- Gregory UrsinoChicago$242K
- Ayman Al-HendyChicago$135K
- Nicole TaskerChicago$125K
- Teresa HubkaChicago$62K
- Magdy MiladChicago$57K
- Angela ChaudhariChicago$52K
- Carlos Sandoval-HerreraChicago$43K
- Ashlesha PatelChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.